SCHEMBL78593

SCHEMBL78593

[CH2]CC=CCCCCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9836518 1.00 FAAH (0.54)
SCHEMBL9836515 1.00 FAAH (0.54)
SCHEMBL78592 1.00
SCHEMBL873608 1.00
SCHEMBL25181826 0.97 FAAH (0.58)
SCHEMBL25181780 0.97 FAAH (0.58)
SCHEMBL23493107 0.97 FAAH (0.58)
SCHEMBL23493106 0.97 FAAH (0.58)
SCHEMBL25185536 0.97 FAAH (0.58)
SCHEMBL25276609 0.97 FAAH (0.58)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 5460 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117983302-A Catalyst containing ferrocene PNP ligand for ethylene selective tetramerization and preparation method and application thereof 华东理工大学 2024-05-07 CN claimed
CN-115141663-B Additive for improving lubricating property of gasoline and gasoline composition 中国石油化工股份有限公司 2023-12-12 CN claimed
CN-116482153-A Imidazoline compound content testing method 中国石油天然气股份有限公司 2023-07-25 CN claimed
CN-115141663-A Additive for improving lubricating performance of gasoline and gasoline composition 中国石油化工股份有限公司 2022-10-04 CN claimed
EP-2822682-B1 MICROCAPSULES AND USES THEREOF FIRMENICH & CIE (CH) 2017-04-26 EP claimed
EP-1937650-B1 HETEROCYCLIC COMPOUNDS S BIO PTE LTD (SG) 2011-06-15 EP claimed
US-20100098691-A1 COMBINATION OF BENZIMIDAZOLE ANTI-CANCER AGENT AND A SECOND ANTI-CANCER AGENT S'BIO PTE LTD (SG) 2010-04-22 US claimed
EP-2131840-A1 COMBINATION OF BENZIMIDAZOLE ANTI-CANCER AGENT AND A SECOND ANTI-CANCER AGENT S*Bio Pte Ltd (SG) 2009-12-16 EP claimed
US-20090048300-A1 Heterocyclic Compounds S*BIO PTE LTD. (SG) 2009-02-19 US claimed
WO-2008108741-A1 COMBINATION OF BENZIMIDAZOLE ANTI-CANCER AGENT AND A SECOND ANTI-CANCER AGENT S*BIO PTE LTD (SG) 2008-09-12 WO claimed
EP-1000070-A4 SILICON-CONTAINING CHAIN EXTENDERS CARDIAC CRC NOMINEES PTY LTD (AU) 2000-06-07 EP claimed
EP-1000070-A1 SILICON-CONTAINING CHAIN EXTENDERS CARDIAC CRC NOMINEES PTY. LTD. (AU) 2000-05-17 EP claimed
EP-0984997-A4 SILICON-BASED POLYCARBONATES CARDIAC CRC NOMINEES PTY LTD (AU) 2000-03-29 EP claimed
EP-0984997-A1 SILICON-BASED POLYCARBONATES CARDIAC CRC NOMINEES PTY. LTD. (AU) 2000-03-15 EP claimed
WO-1999003863-A1 SILICON-CONTAINING CHAIN EXTENDERS CARDIAC CRC NOMINEES PTY. LTD. (AU) 1999-01-28 WO claimed
WO-1998054242-A1 SILICON-BASED POLYCARBONATES CARDIAC CRC NOMINEES PTY. LTD. (AU) 1998-12-03 WO claimed
US-5571449-A LIQUID CRYSTALS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1996-11-05 US claimed
US-5190689-A Polymer materials having liquid-crystalline phases MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1993-03-02 US claimed
US-4683222-A STIMULANTS FOR IMMUNE SYSTEM BAYER AKTIENGESELLSCHAFT (DE) 1987-07-28 US claimed
US-3936523-A CROSSLINKED POLYETHYLENE SIEMENS AKTIENGESELLSCHAFT (DT) 1976-02-03 US claimed